Cargando…

Role of pharmacogenomics in the treatment of tuberculosis: a review

BACKGROUND: Tuberculosis is one of the major public health problems worldwide. Modern antituberculous treatment can cure most patients; cure rates > 95% are achieved with standard short-course chemotherapy regimens containing isoniazid, rifampicin, pyrazinamide, and ethambutol among patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramachandran, Geetha, Swaminathan, Soumya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513231/ https://www.ncbi.nlm.nih.gov/pubmed/23226065 http://dx.doi.org/10.2147/PGPM.S15454

Ejemplares similares

Intrapatient variability in plasma rifampicin & isoniazid in tuberculosis patients
por: Kumar, A. K. Hemanth, et al.
Publicado: (2018)

Pharmacogenomics of Hypertension Treatment
por: Rysz, Jacek, et al.
Publicado: (2020)

N-acetyltransferase gene polymorphisms & plasma isoniazid concentrations in patients with tuberculosis
por: Hemanth Kumar, A. K., et al.
Publicado: (2017)

Food significantly reduces plasma concentrations of first-line anti-tuberculosis drugs
por: Kumar, Agibothu Kupparam Hemanth, et al.
Publicado: (2017)

Diagnosis & treatment of tuberculosis in HIV co-infected patients
por: Padmapriyadarsini, C., et al.
Publicado: (2011)

Technologies for Pharmacogenomics: A Review
por: van der Lee, Maaike, et al.
Publicado: (2020)

Pharmacogenomic Approaches to Asthma Treatment
por: Cho, Sang-Heon
Publicado: (2010)

Can Urine Lamivudine Be Used to Monitor Antiretroviral Treatment Adherence?
por: Kumar, Agibothu K Hemanth, et al.
Publicado: (2006)

Pharmacogenomics on the Treatment Response in Patients with Psoriasis: An Updated Review
por: Wang, Ching-Ya, et al.
Publicado: (2023)

A Review of the Important Role of CYP2D6 in Pharmacogenomics
por: Taylor, Christopher, et al.
Publicado: (2020)

Role of pharmacogenomics in drug discovery and development
por: Surendiran, A., et al.
Publicado: (2008)

Tuberculosis in India - Can we ensure a test, treatment & cure for all?
por: Swaminathan, Soumya
Publicado: (2014)

Drug Concentration Thresholds Predictive of Therapy Failure and Death in Children With Tuberculosis: Bread Crumb Trails in Random Forests
por: Swaminathan, Soumya, et al.
Publicado: (2016)

Pharmacogenomics of Cancer Pain Treatment Outcomes in Asian Populations: A Review
por: Satkunananthan, Shobha Elizabeth, et al.
Publicado: (2022)

Diabetes: Is There a Future for Pharmacogenomics Guided Treatment?
por: Pearson, Ewan R.
Publicado: (2019)

Pharmacogenomics of Antibiotics
por: Stocco, Gabriele, et al.
Publicado: (2020)

Pulmonary tuberculosis among tribals in India: A systematic review & meta-analysis
por: Thomas, Beena E., et al.
Publicado: (2015)

Pharmacogenomics and the Management of Mood Disorders—A Review
por: Kleine Schaars, Kristian, et al.
Publicado: (2023)

Pharmacogenomics of Monoclonal Antibodies for the Treatment of Rheumatoid Arthritis
por: Lim, Sung Ho, et al.
Publicado: (2022)

Implications of Pharmacogenomics in the Current and Future Treatment of Asthma
por: Morrow, Thomas J.
Publicado: (2007)

Disease burden and the role of pharmacogenomics in African populations
por: Mpye, K. L., et al.
Publicado: (2017)

Is there a role of pharmacogenomics in Africa
por: Matimba, A., et al.
Publicado: (2016)

The role of genetics in pre-eclampsia and potential pharmacogenomic interventions
por: Williams, Paula Juliet, et al.
Publicado: (2012)

The Roles of Common Variation and Somatic Mutation in Cancer Pharmacogenomics
por: Chan, Hiu Ting, et al.
Publicado: (2019)

HIV treatment cascade in tuberculosis patients
por: Lessells, Richard J., et al.
Publicado: (2015)

Dyslipidemia among HIV-infected Patients with Tuberculosis Taking Once-daily Nonnucleoside Reverse-Transcriptase Inhibitor–Based Antiretroviral Therapy in India
por: Padmapriyadarsini, Chandrasekaran, et al.
Publicado: (2011)

Pharmacogenomics and Morphine
por: Ofoegbu, Adaku, et al.
Publicado: (2021)

Pharmacogenomics of Mood Stabilizers in the Treatment of Bipolar Disorder
por: Squassina, Alessio, et al.
Publicado: (2010)

The Role of Pharmacogenomics in Opioid Prescribing
por: Wong, Aaron K., et al.
Publicado: (2022)

Pharmacogenomic insights into treatment and management of statin-induced myopathy
por: Peters, Bas JM, et al.
Publicado: (2009)

Pharmacogenomic application of the haptoglobin genotype in the treatment of HDL dysfunction
por: Schwartz, Avery, et al.
Publicado: (2009)

Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics
por: Lally, John, et al.
Publicado: (2016)

Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment
por: Bignucolo, Alessia, et al.
Publicado: (2017)

Pharmacogenomic Assessment of Patients with Colorectal Cancer and Potential Treatments
por: Bruera, Gemma, et al.
Publicado: (2020)

Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments
por: Lin, Eugene, et al.
Publicado: (2021)

Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms
por: Vuic, Barbara, et al.
Publicado: (2023)

Cost-effectiveness of a Pharmacogenomic Test for Stratified Isoniazid Dosing in Treatment of Active Tuberculosis
por: Rens, Neil E, et al.
Publicado: (2020)

Current trends and intricacies in the management of HIV-associated pulmonary tuberculosis
por: Gopalan, Narendran, et al.
Publicado: (2016)

Pharmacogenomics: methods and protocols
por: Lai, C
Publicado: (2006)

Pharmacogenomics of pediatric asthma
por: Gupta, Sarika, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_61gfs52fnbiocel79u6pggb48g